Autophagy in aging-related diseases and cancer: Principles, regulatory mechanisms and therapeutic potential
Na Wu,Wenhui Zheng,Yundong Zhou,Yu Tian,Min Tang,Xiaoqiang Feng,Milad Ashrafizadeh,Yuzhuo Wang,Xiaojia Niu,Murtaza Tambuwala,Lingzhi Wang,Vinay Tergaonkar,Gautam Sethi,Daniel Klionsky,Li Huang,Ming Gu
DOI: https://doi.org/10.1016/j.arr.2024.102428
2024-07-20
Abstract:Macroautophagy/autophagy is primarily accountable for the degradation of damaged organelles and toxic macromolecules in the cells. Regarding the essential function of autophagy for preserving cellular homeostasis, changes in, or dysfunction of, autophagy flux can lead to disease development. In the current paper, the complicated function of autophagy in aging-associated pathologies and cancer is evaluated, highlighting the underlying molecular mechanisms that can affect longevity and disease pathogenesis. As a natural biological process, a reduction in autophagy is observed with aging, resulting in an accumulation of cell damage and the development of different diseases, including neurological disorders, cardiovascular diseases, and cancer. The MTOR, AMPK, and ATG proteins demonstrate changes during aging, and they are promising therapeutic targets. Insulin/IGF1, TOR, PKA, AKT/PKB, caloric restriction and mitochondrial respiration are vital for lifespan regulation and can modulate or have an interaction with autophagy. The specific types of autophagy, such as mitophagy that degrades mitochondria, can regulate aging by affecting these organelles and eliminating those mitochondria with genomic mutations. Autophagy and its specific types contribute to the regulation of carcinogenesis and they are able to dually enhance or decrease cancer progression. Cancer hallmarks, including proliferation, metastasis, therapy resistance and immune reactions, are tightly regulated by autophagy, supporting the conclusion that autophagy is a promising target in cancer therapy.